3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
96
Inflammatory Breast Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
8
Breast Neoplasms, Male
6
Breast Carcinoma In Situ
6
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Neoplasms
3
Locally Advanced Breast Cancer
2
HER2-positive Breast Cancer
2
Colorectal Neoplasms
2
Breast Cancer Patients
2
Stress, Psychological
1
Postoperative Complications
1
Pathologic Complete Response
1
Neovascularization, Pathologic
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Motor Activity
1
Margins of Excision
1
Inflammation
1
Infertility
1
High-Risk Cancer
1
Head and Neck Neoplasms
1
Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Lobular
1
Breast Cancer-specific Survival
1
Breast Cancer Metastatic
1
Breast Cancer Invasive
1
Interventions
Zoledronic Acid
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neovascularization, Pathologic
×
Neoadjuvant Therapy
×
Breast
×
Clear all
NCT01367288
2019-05-28
NEOZOL
Hospices Civils de Lyon
Phase 2
Completed
53 enrolled